Victoria Boswell‐Smith

The Pharmacology of Two Novel Long-Acting Phosphodiesterase 3/4 Inhibitors, RPL554 [9,10-Dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2 H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-Dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4 H-pyrimido[6,1-a]isoquinolin-4-one]

Victoria Boswell‐Smith, Domenico Spina, Alec W. Oxford et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 106 citations

The effect of selective phosphodiesterase isoenzyme inhibition on neutrophil function in vitro

Neil A. Jones, Victoria Boswell‐Smith, R. Lever et al. · Pulmonary Pharmacology & Therapeutics · 2004 · 100 citations

Inflammation, Autoimmune Disease, Granulocyte +8

Potent, nonpeptide inhibitors of human mast cell tryptase. Synthesis and biological evaluation of novel spirocyclic piperidine amide derivatives

Michael J. Costanzo, Stephen C. Yabut, Han-Cheng Zhang et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

Medicinal Chemistry, Allergy, Medicine +9

PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast.

Victoria Boswell‐Smith, Domenico Spina · PubMed · 2007 · 45 citations

Asthma, Antifibrotic Therapy, Inflammatory Lung Disease +17

Mechanism of adenosine‐induced airways obstruction in allergic guinea pigs

Sandra Keir, Victoria Boswell‐Smith, Domenico Spina et al. · British Journal of Pharmacology · 2006 · 31 citations · Full text